Search research articles
Contact Us
Filters
Showing results (21-30 of 35) with videos related to
Page
of 4
Sort By:
Clinical and Translational Radiation Oncology
|
April 17, 2020
In reply to Drs Magrini, Mazzola, Greco, Alongi, Buglione
Richard Simcock, Toms Vengaloor Thomas, Christopher Estes, et al.
Journal of Geriatric Oncology
|
November 16, 2021
International efforts in geriatric radiation oncology
Amara Naseer, Anthea Cree, Richard Simcock, et al.
Clinical and Translational Radiation Oncology
|
September 15, 2021
Time management: Improving the timing of post-prostatectomy radiotherapy, clinical trials, and knowledge translation
Kai Yun Ooi, Ian Pereira, Himanshu Nagar, et al.
Anticancer Research
|
March 28, 2023
Biphenotypic Sinonasal Sarcoma: Case Reports of Diagnostic Findings and Clinical Management of 3 Cases
Yolanda Augustin, Shane Zaidi, Robin L Jones, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 2, 2022
An International Expert Delphi Consensus to Develop Dedicated Geriatric Radiation Oncology Curriculum Learning Outcomes
Lucinda Morris, Sandra Turner, Niluja Thiruthaneeswaran, et al.
Breast (Edinburgh, Scotland)
|
March 9, 2025
Awareness of genomic testing among patients with breast cancer in Europe
Antonella Cardone, Dany Bell, Conchi Biurrun, et al.
The Lancet. Oncology
|
November 17, 2023
The future of cancer care in the UK-time for a radical and sustainable National Cancer Plan
Ajay Aggarwal, Ananya Choudhury, Nicola Fearnhead, et al.
Tumori
|
October 30, 2025
Postoperative radiotherapy for stage IV breast cancer following primary tumor removal: Systematic review and meta-analysis
Anna Maria Merlotti, Stefania Martini, Anna Maria Vandone, et al.
Breast (Edinburgh, Scotland)
|
November 4, 2021
Palbociclib in combination with aromatase inhibitors in patients ≥ 75 years with oestrogen receptor-positive, human epidermal growth factor receptor 2 negative advanced breast cancer: A real-world multicentre UK study
Salma El Badri, Bilal Tahir, Kirsty Balachandran, et al.
Lancet (London, England)
|
June 11, 2019
6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial
Helena M Earl, Louise Hiller, Anne-Laure Vallier, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 35) with videos related to
Sort By:
Page
of 4
Clinical and Translational Radiation Oncology
|
April 17, 2020
In reply to Drs Magrini, Mazzola, Greco, Alongi, Buglione
Richard Simcock, Toms Vengaloor Thomas, Christopher Estes, et al.
Journal of Geriatric Oncology
|
November 16, 2021
International efforts in geriatric radiation oncology
Amara Naseer, Anthea Cree, Richard Simcock, et al.
Clinical and Translational Radiation Oncology
|
September 15, 2021
Time management: Improving the timing of post-prostatectomy radiotherapy, clinical trials, and knowledge translation
Kai Yun Ooi, Ian Pereira, Himanshu Nagar, et al.
Anticancer Research
|
March 28, 2023
Biphenotypic Sinonasal Sarcoma: Case Reports of Diagnostic Findings and Clinical Management of 3 Cases
Yolanda Augustin, Shane Zaidi, Robin L Jones, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 2, 2022
An International Expert Delphi Consensus to Develop Dedicated Geriatric Radiation Oncology Curriculum Learning Outcomes
Lucinda Morris, Sandra Turner, Niluja Thiruthaneeswaran, et al.
Breast (Edinburgh, Scotland)
|
March 9, 2025
Awareness of genomic testing among patients with breast cancer in Europe
Antonella Cardone, Dany Bell, Conchi Biurrun, et al.
The Lancet. Oncology
|
November 17, 2023
The future of cancer care in the UK-time for a radical and sustainable National Cancer Plan
Ajay Aggarwal, Ananya Choudhury, Nicola Fearnhead, et al.
Tumori
|
October 30, 2025
Postoperative radiotherapy for stage IV breast cancer following primary tumor removal: Systematic review and meta-analysis
Anna Maria Merlotti, Stefania Martini, Anna Maria Vandone, et al.
Breast (Edinburgh, Scotland)
|
November 4, 2021
Palbociclib in combination with aromatase inhibitors in patients ≥ 75 years with oestrogen receptor-positive, human epidermal growth factor receptor 2 negative advanced breast cancer: A real-world multicentre UK study
Salma El Badri, Bilal Tahir, Kirsty Balachandran, et al.
Lancet (London, England)
|
June 11, 2019
6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial
Helena M Earl, Louise Hiller, Anne-Laure Vallier, et al.
Page
of 4